New York, NY, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, and Software & Services), by Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Enzyme Immunoassays, Radioimmunoassay, and Others), by Technology (ELISA, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Others), by Application (Infectious Disease, Endocrinology, Oncology, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, and Others), and by End-User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global immunoassay market was valued approximately USD 19.17 billion in 2018 and is expected to generate around USD 29.79 billion by 2025, at a CAGR of around 6.5% between 2019 and 2025.

Immunoassay is a type of biochemistry technique that is used either qualitatively or quantitatively to detect the presence of analytes. The analytes present can be in the form of large proteins or antibodies that may be produced due to an infection. This type of test can be used in laboratories or at the site itself. Antibodies or antigens are used as biorecognition agents for detecting the presence of analytes. The growing prevalence of other chronic and infectious diseases, such as tuberculosis, AIDS, etc., is projected to further fuel the immunoassay market over the estimated timeframe.

Browse through 88 Tables & 47 Figures spread over 110 Pages and in-depth TOC on “Global Immunoassay Market: Size, Share, Industry Trends, Segments, Analysis and Forecast, 2018–2025”.

Request Free Sample Report of Global Immunoassay Market Report @ https://www.zionmarketresearch.com/sample/immunoassay-market

The global immunoassay market is divided into product and service, technology, application, platform, and end-user. By product and service, the market is divided into reagents and kits, software and services, and analyzers. The reagents and kits segment is anticipated to dominate the immunoassay market over the forecast time period, owing to the increasing prevalence of chronic and infectious diseases

By platform, the immunoassay market is segmented into fluorescence immunoassays, radioimmunoassays, enzyme immunoassays, chemiluminescence immunoassays, and others. The enzyme immunoassays segment is anticipated to grow considerably in the global market due to its accurate results related to the detection of various diseases.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/immunoassay-market

By technology, the market is segmented into ELISA, ELISPOT, immuno-PCR, rapid tests, western blotting, and others. ELISA dominated the market in 2018, due to its use in the detection of various diseases, such as cancer, infectious disease, and detection and monitoring of the therapeutic drug level.

The application segment of the market includes oncology, endocrinology, cardiology, infectious diseases, autoimmune disorders, hematology and blood screening, and others. Infectious diseases are expected to dominate the immunoassay market in the upcoming years, owing to the growing prevalence of tuberculosis in developing nations, such as India and China. The oncology segment is expected to show the highest growth rate in the future, owing to the increasing number of people suffering from cancer and growing research and development activities related to cancer.

Request for Discount on This Report: https://www.zionmarketresearch.com/requestdiscount/immunoassay-market

By end-user, the market is segmented into pharmaceutical and biotechnology companies, clinical laboratories, contract research organization, hospitals, and others. Hospitals are anticipated to dominate the immunoassay market globally, owing to the presence of laboratories conducting diagnosis and tests and their high patient pool suffering from chronic diseases.

By region, North America is projected to dominate the global immunoassay market in the upcoming years. According to the Centers for Medicare and Medicaid Services (CMS), healthcare spending in the U.S. was projected to increase from USD 2.7 trillion to USD 4.6 trillion in the period from 2011 to 2018. This rapid increase in the healthcare expenditure can be attributed to the increased spending by the middle-class population and rising health awareness in North America. The increasing use of automated techniques for the detection of chronic diseases, growing prevalence of oncology and other chronic diseases, rising introduction of latest technologies, rapid technological advancements related to disease detection, and growing need for reagents and novel biomarkers are anticipated to drive the North American immunoassay market in the future.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/immunoassay-market

Europe is estimated to acquire the second largest revenue share after North America globally in the years ahead. According to Eurostat, in 2016, approximately 19.2% of the European population was aged above 65. The presence of a huge geriatric population base that suffers from chronic or infectious diseases is likely to fuel the immunoassay market in the future. The rising number of research activities related to oncology, increasing government funding for research related to immunology, and growing introduction of technologically updated products are some other factors expected to drive the European immunoassay market over the estimated timeframe.

Asia Pacific is anticipated to register the highest rate of growth over the forecast time period. According to the WHO (World Health Organization), about half of children’s deaths were caused by infections. The WHO also estimated that about 1 million new cases of tuberculosis are registered in China. The rising prevalence of infectious diseases, like tuberculosis, is projected to fuel the region’s immunoassay market in the future. The growing funding by the government in the field of research, increasing establishments of pharmaceutical and biotechnological companies, and the rising introduction of products by companies in China and India are some of the other factors projected to drive the Asia Pacific immunoassay market in the upcoming years. The increasing production of drugs, vaccines, and new biologics for treating various diseases and growing clinical research in developing countries, such as India and China, are also anticipated to boost the growth of this regional market in the years ahead.

Browse the full “Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, and Software & Services), by Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Enzyme Immunoassays, Radioimmunoassay, and Others), by Technology (ELISA, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Others), by Application (Infectious Disease, Endocrinology, Oncology, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, and Others), and by End-User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/immunoassay-market

The Middle Eastern and African and Latin American regions are projected to demonstrate a steady growth in the global immunoassay market over the forecast time period. This can be attributed to the growing prevalence of infectious and chronic diseases, rising awareness about immunoassay techniques, increasing healthcare expenditure, improvement in healthcare infrastructure, and the rising number of clinical research studies.

Some key players of the global immunoassay market are Siemens, Roche, Abbott Laboratories, Danaher Corporation, QIAGEN, Thermo Fischer Scientific, Bio-Rad Laboratories, Agilent Technologies, bioMerieux, Merck, Bio-Techne Corporation, and PerkinElmer.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/1768

This report segments the global immunoassay market into:

Global Immunoassay Market: Product and Service Analysis

  • Reagents and Kits
  • Analyzers
  • Software and Services
  • Global Immunoassay Market: Platform Analysis
  • Chemiluminescence Immunoassays (CLIAs)
  • Fluorescence Immunoassays (FIAs)
  • Enzyme Immunoassays (EIs)
  • Radioimmunoassays (RIAs)
  • Others

Global Immunoassay Market: Technology Analysis

  • ELISA
  • Rapid Tests
  • Western Blotting
  • ELISPOT
  • Immuno-PCR
  • Others

Global Immunoassay Market: Application Analysis

  • Infectious Disease
  • Endocrinology
  • Oncology
  • Cardiology
  • Hematology and Blood Screening
  • Autoimmune Disorders
  • Others

Global Immunoassay Market: End-User Analysis

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies 
  • Contract Research Organizations (CROs)
  • Blood Banks
  • Others

Global Immunoassay Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://zmrindustryjournal.us  | http://zmrresearchnews.us | http://zmrmarketjournal.com  | https://zmrnewsjournal.us | http://zmrnewsmagazine.com | https://zmrnewsblog.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com